Board member at cbdMD (YCBD) receives 1,572-share stock grant
Rhea-AI Filing Summary
Roe Kevin Charles reported acquisition or exercise transactions in this Form 4 filing.
cbdMD, Inc. director Kevin Charles Roe received a grant of 1,572 restricted stock units, each representing a right to one share of common stock, as compensation for Board service under the company’s 2021 or 2025 Equity Compensation Plan.
The award was approved by the Compensation, Corporate Governance and Nominating Committee and carries a stated price of $0.00 per unit, reflecting its nature as equity compensation rather than a market purchase. The restricted stock units vest quarterly on June 30, 2026, September 30, 2026, December 31, 2026 and March 31, 2027. Following this grant, Roe directly holds 26,707 shares or share-equivalent units of cbdMD common stock.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 1,572 shares
Net Buy
1 txn
Insider
Roe Kevin Charles
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 1,572 | $0.00 | $0.00 |
Holdings After Transaction:
Common Stock — 26,707 shares (Direct)
Footnotes (1)
- F1. Represents restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The grant was exempt from Section 16(b) under the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder as it was approved in advance by the Issuer's Compensation, Corporate Governance and Nominating Committee, which is comprised of three non-employee directors. The restricted stock units vest quarterly on June 30, 2026, September 30, 2026, December 31, 2026 and March 31, 2027. The restricted stock units were issued under the 2021 or 2025 Equity Compensation Plan as compensation to the Reporting Person for services on the Issuer's Board of Directors.
Key Figures
RSU grant size: 1,572 units
Grant price per unit: $0.00 per unit
Holdings after grant: 26,707 shares
+2 more
5 metrics
RSU grant size
1,572 units
Restricted stock units granted to director on April 14, 2026
Grant price per unit
$0.00 per unit
Equity compensation award, not a market purchase
Holdings after grant
26,707 shares
Total cbdMD common stock or equivalents held directly after transaction
First vesting date
June 30, 2026
Initial quarterly vesting for the restricted stock units
Final vesting date
March 31, 2027
Final quarterly vesting installment for the RSU award
Key Terms
restricted stock units, Section 16(b), Rule 16b-3, Equity Compensation Plan
4 terms
restricted stock units financial
"Represents restricted stock units. Each restricted stock unit represents a contingent right"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Section 16(b) regulatory
"The grant was exempt from Section 16(b) under the Securities Exchange Act of 1934"
A federal rule that requires company insiders—like officers, directors and large shareholders—to return any profits made from buying and selling the company’s stock within a six-month window. It matters to investors because it discourages short-term trades that could exploit non-public information and helps protect outside shareholders by creating a simple, enforceable way to recover unfair gains, much like a rule stopping someone from flipping a limited-edition item for quick profit after getting early access.
Rule 16b-3 regulatory
"by virtue of Rule 16b-3 promulgated thereunder as it was approved"
Rule 16b-3 is a Securities and Exchange Commission regulation that exempts certain routine, pre-approved transactions by company insiders from automatic liability for short-term trading profits. It acts like a safe harbor: if an insider follows a formal plan or the board approves specific transactions in advance, profits from buying and selling company stock within six months are not automatically reclaimed. Investors care because the rule clarifies when insider trades are permissible and reduces uncertainty about potential clawbacks.
Equity Compensation Plan financial
"issued under the 2021 or 2025 Equity Compensation Plan as compensation"
A plan by which a company gives employees, directors or contractors ownership or the right to buy ownership in the company through stock, options or similar awards — think of promising slices of the company pie as part of someone's pay. It matters to investors because these awards can change the number of shares outstanding, affect reported profits and influence management’s decisions; large or generous plans can dilute existing holders and alter incentives over time.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transaction did cbdMD (YCBD) report for Kevin Charles Roe?
cbdMD reported a grant of 1,572 restricted stock units to director Kevin Charles Roe. Each unit represents a contingent right to receive one share of common stock as compensation for his service on the company’s Board of Directors.
Is Kevin Charles Roe’s cbdMD (YCBD) transaction a market purchase or a compensation award?
The transaction is a compensation award, not a market purchase. Roe received 1,572 restricted stock units at a stated price of $0.00 per unit, granted under cbdMD’s equity compensation plan and approved by the Board’s compensation committee.
When do Kevin Charles Roe’s cbdMD (YCBD) restricted stock units vest?
The 1,572 restricted stock units vest in four quarterly installments. Vesting dates are June 30, 2026, September 30, 2026, December 31, 2026 and March 31, 2027, subject to the usual conditions that apply to equity compensation awards.
Under which plan were Kevin Charles Roe’s cbdMD (YCBD) restricted stock units issued?
The restricted stock units were issued under cbdMD’s 2021 or 2025 Equity Compensation Plan. These plans provide equity-based compensation to directors, with this specific grant serving as compensation for Roe’s ongoing service on the company’s Board of Directors.
Was Kevin Charles Roe’s cbdMD (YCBD) equity grant exempt from Section 16(b)?
Yes. The grant was exempt from Section 16(b) under Rule 16b-3 because it was approved in advance by cbdMD’s Compensation, Corporate Governance and Nominating Committee, which is composed of three non-employee directors overseeing such equity awards.